Abstract
SummaryAt 175 days of age it was found that DMBA given to female Sprague-Dawley rats at 2 days of age was followed by a high incidence of mammary fibroadenoma. DMBA given at 52 days of age was followed by a high incidence of mammary adenocarcinoma. When both DMBA treatments were given to the same animals, the mammary adenofibroma incidence was much the same as in the rats given only DMBA at 2 days of age and mammary adenocarcinoma incidence was much the same as in animals given only DMBA at 52 days of age. No significant interaction between two doses of DMBA given at both 2 and 52 days of age on mammary neoplasia was noted.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
